Home Tags AJA001

Tag: AJA001

Defloria autism study

DeFloria Receives Investigational New Drug Application Clearance for Autism Spectrum Disorder

LITTLETON, Colo. -- U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for AJA001, an orally delivered,...
Charlotte's Web Holdings Inc. logo

DeFloria LLC Commences Phase 1 Clinical Program for Full Spectrum Hemp Botanical Drug

DENVER - Charlotte's Web Holdings Inc., A market leader in full-spectrum hemp extract wellness products, and AJNA BioSciences PBC, a botanical drug development company focused...

INDUSTRY REPORTS

Continue to the category

BUSINESS & STRATEGY

Continue to the category

TOP TRENDING ARTICLES